Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -79.51 | 24.00 |
PEG Ratio (TTM) | -6.76 | -2.91 |
P/S Ratio (TTM) | 1.49 | 9.64 |
P/B Ratio (TTM) | 2.33 | 19.79 |
P/FCF Ratio (TTM) | 11.67 | 21.23 |
Price to 5YR AVG Earnings Ratio | N/A | 31.75 |
Price to 5YR AVG FCF Ratio | N/A | 26.61 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -2.49% | 13.73% |
ROE (TTM) | -2.98% | 61.74% |
Net Profit Margin (TTM) | -1.85% | 33.03% |
ROIC 5YR AVG | N/A | 40.51% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -358.62% | -294.36% | N/A |
Revenue | 2.06% | 34.72% | N/A |
Net Income | -267.85% | -301.33% | N/A |
Cash Flow | 91.48% | 47.67% | N/A |
Health (67%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.27 | 2.79 |
Quick Ratio (TTM) | 4.27 | 2.35 |
D/E Ratio (TTM) | 0.02 | 1.43 |
Interest Coverage (TTM) | 5.00 | 17.89 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 9.48 | 5.68 |
LTL to 5YR AVG FCF | N/A | 3.22 |
Shares Outstanding Growth 5YR AVG | N/A | 55.21% |